MEDICUS PHARMA LTD. Increase Decrease In Operating Lease Liability
MEDICUS PHARMA LTD. (MDCX) reported Increase Decrease In Operating Lease Liability of -$76.61 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-12
- MEDICUS PHARMA LTD. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$36.09K.
- MEDICUS PHARMA LTD. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$40.51K.
- MEDICUS PHARMA LTD. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$36.44K.
- MEDICUS PHARMA LTD. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$50.06K, a 1006.36% decline year-over-year.
- MEDICUS PHARMA LTD. increase decrease in operating lease liability for fiscal 2025 was -$142.61K.
- MEDICUS PHARMA LTD. increase decrease in operating lease liability for fiscal 2024 was -$70.08K.
- MEDICUS PHARMA LTD. increase decrease in operating lease liability for fiscal 2023 was $0.00.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$36.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$76.61K 10-Q · filed 2026-08-12 | -$113.05K derived: sum of 3 quarters · filed 2026-08-12 | -$163.10K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$40.51K 10-Q · filed 2026-05-14 | -$76.95K derived: sum of 2 quarters · filed 2026-05-14 | -$127.01K derived: sum of 3 quarters · filed 2026-05-14 | -$155.55K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$36.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$86.50K derived: sum of 2 quarters · filed 2026-03-25 | -$115.04K derived: sum of 3 quarters · filed 2026-08-12 | -$142.61K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$50.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$78.60K derived: sum of 2 quarters · filed 2026-08-12 | -$106.17K 10-Q · filed 2025-11-14 | -$141.21K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$28.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$56.11K 10-Q · filed 2026-08-12 | -$91.15K derived: sum of 3 quarters · filed 2026-08-12 | -$85.63K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$27.57K 10-Q · filed 2026-05-14 | -$62.62K derived: sum of 2 quarters · filed 2026-05-14 | -$57.09K derived: sum of 3 quarters · filed 2026-05-14 | -$97.66K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$35.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$29.52K derived: sum of 2 quarters · filed 2026-03-25 | -$70.08K derived: sum of 3 quarters · filed 2026-03-25 | -$70.08K 10-K · filed 2026-03-25 |
| 2024-09-30 | $5.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$35.04K derived: sum of 2 quarters · filed 2025-11-14 | -$35.04K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$40.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$40.56K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |